| Literature DB >> 25705657 |
Kenji Takeuchi1, Michiko Furuta1, Toru Takeshita1, Yukie Shibata1, Yoshihiro Shimazaki2, Sumio Akifusa3, Toshiharu Ninomiya4, Yutaka Kiyohara5, Yoshihisa Yamashita1.
Abstract
The purpose of this study was to determine distinct risk factors causing reduced salivary flow rate in a community-dwelling population using a prospective cohort study design. This was a 5-year follow-up survey of 1,377 community-dwelling Japanese individuals aged ≥40 years. The salivary flow rate was evaluated at baseline and follow-up by collecting stimulated saliva. Data on demographic characteristics, use of medication, and general and oral health status were obtained at baseline. The relationship between reduced salivary flow rate during the follow-up period and its predictors was evaluated after adjustment for confounding factors. In a multivariate logistic regression model, higher age and plaque score and lower serum albumin levels were significantly associated with greater odds of an obvious reduction in salivary flow rate (age per decade, odds ratio [OR] = 1.25, 95% confidence interval [CI] = 1.03-1.51; serum albumin levels <4 g/dL, OR = 1.60, 95% CI = 1.04-2.46; plaque score ≥1, OR = 1.53, 95% CI = 1.04-2.24). In a multivariate linear regression model, age and plaque score remained independently associated with the increased rate of reduced salivary flow. These results suggest that aging and plaque score are important predictors of reduced salivary flow rate in Japanese adults.Entities:
Mesh:
Year: 2015 PMID: 25705657 PMCID: PMC4332456 DOI: 10.1155/2015/381821
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Baseline characteristics of participants (n = 1,377).
|
| % | Age (mean ± SD) | Men (%) | |
|---|---|---|---|---|
| Total | 1,377 | 100.0 | 58.6 ± 9.9 | 43.2 |
| Salivary flow rate (mL/min) | ||||
| 1.0–2.0 | 274 | 19.9 | 59.1 ± 10.3 | 27.4 |
| 2.0–3.0 | 405 | 29.4 | 59.5 ± 9.6 | 32.1 |
| 3.0–4.0 | 381 | 27.7 | 58.6 ± 9.8 | 47.0 |
| ≧4.0 | 317 | 23.0 | 56.9 ± 10.1 | 66.6 |
| Age | ||||
| 40–49 | 282 | 20.5 | 44.9 ± 2.9 | 37.9 |
| 50–59 | 482 | 35.0 | 55.0 ± 2.9 | 43.6 |
| 60–69 | 402 | 29.2 | 64.3 ± 2.8 | 42.3 |
| ≧70 | 211 | 15.3 | 74.1 ± 3.7 | 51.2 |
| Medical history of stroke | ||||
| Yes | 32 | 2.3 | 65.9 ± 7.1 | 56.3 |
| No | 1,345 | 97.7 | 58.4 ± 9.9 | 42.9 |
| Use of antihypertensive agent | ||||
| Yes | 339 | 24.6 | 64.6 ± 8.8 | 51.3 |
| No | 1,038 | 75.4 | 56.6 ± 9.5 | 40.6 |
| Smoking habits | ||||
| Current smoker | 251 | 18.2 | 54.9 ± 8.6 | 79.3 |
| Noncurrent smoker | 1,126 | 81.8 | 59.4 ± 10.0 | 35.2 |
| Alcohol intake | ||||
| Current drinker | 753 | 54.7 | 57.7 ± 9.8 | 59.9 |
| Noncurrent drinker | 624 | 45.3 | 59.7 ± 10.0 | 23.1 |
| Tooth brushing frequency | ||||
| Once a day | 416 | 30.2 | 59.2 ± 10.4 | 64.7 |
| Twice or more a day | 957 | 69.5 | 58.3 ± 9.8 | 33.8 |
| Missing | 4 | 0.3 | 59.5 ± 4.2 | 75.0 |
| BMI | ||||
| ≧25 | 373 | 27.1 | 58.5 ± 9.6 | 48.3 |
| <25 | 1,004 | 72.9 | 58.6 ± 10.1 | 41.3 |
| Serum albumin (g/dL) | ||||
| Normal (≧4) | 1,168 | 84.8 | 58.2 ± 9.8 | 43.2 |
| Low (<4) | 209 | 15.2 | 60.8 ± 10.3 | 43.1 |
| 2 h postload plasma glucose levels (mg/dL) | ||||
| Diabetes (≧200) | 141 | 10.2 | 63.2 ± 9.7 | 63.1 |
| Nondiabetes (<200) | 1,213 | 88.1 | 57.9 ± 9.8 | 41.1 |
| Missing | 23 | 1.7 | 64.8 ± 8.8 | 34.8 |
| Dental prosthetic status | ||||
| ≧20 remaining natural teeth with dentures | 92 | 6.7 | 64.8 ± 8.4 | 50.0 |
| ≧20 remaining natural teeth without dentures | 1,091 | 79.2 | 56.7 ± 9.4 | 42.6 |
| <20 remaining natural teeth with dentures | 150 | 10.9 | 67.3 ± 8.5 | 41.3 |
| <20 remaining natural teeth without dentures | 44 | 3.2 | 61.8 ± 8.1 | 50.0 |
| Plaque score | ||||
| ≧1 | 365 | 26.5 | 61.4 ± 10.5 | 57.0 |
| <1 | 1,012 | 73.5 | 57.5 ± 9.5 | 38.2 |
| Periodontal status | ||||
| Periodontitis | 640 | 46.5 | 60.3 ± 9.8 | 50.9 |
| Nonperiodontitis | 737 | 53.5 | 57.1 ± 9.8 | 36.5 |
SD: standard deviation.
Association of obvious reduction in salivary flow rate with its predictors determined by using logistic regression.
| Model 1 | Model 2 | Obvious reduction in salivary flow rate (%) | PAF (%) | |
|---|---|---|---|---|
| Crude OR | Multivariate ORa
| |||
| Salivary flow rate (mL/min) | 0.98 (0.86–1.11) | NA | NA | |
| Age per decadeb | 1.38 (1.16–1.63) | 1.25 (1.03–1.51) | NA | NA |
| Sex (ref. women) | ||||
| Men | 1.28 (0.91–1.80) | 1.11 (0.78–1.58) | 12.3 | 9.6 |
| Medical history of stroke | 2.82 (1.25–6.40) | 2.14 (0.92–4.97) | 25.0 | 3.1 |
| Use of antihypertensive agents | 1.31 (0.90–1.91) | 13.0 | 6.3 | |
| Smoking habits (ref. noncurrent smoker) | ||||
| Current smoker | 1.08 (0.71–1.67) | 11.6 | 1.4 | |
| Alcohol intake (ref. noncurrent drinker) | ||||
| Current drinker | 0.94 (0.67–1.32) | 10.6 | −3.0 | |
| Tooth brushing frequency (ref. twice or more a day) | ||||
| Once a day | 1.31 (0.92–1.87) | 12.7 | 7.6 | |
| BMI (ref. <25) | ||||
| ≥25 | 0.77 (0.51–1.15) | 9.1 | −6.1 | |
| Serum albumin levels [ref. normal (≥4 g/dL)] | ||||
| Low (<4 g/dL) | 1.68 (1.11–2.56) | 1.60 (1.04–2.46) | 15.8 | 8.0 |
| 2 h postload plasma glucose levels [ref. nondiabetes (<200 mg/dL)] | ||||
| Diabetes (≥200 mg/dL) | 1.24 (0.73–2.10) | 12.8 | 2.1 | |
| Dental prosthetic status (ref. ≥20 remaining natural teeth without dentures) | ||||
| ≥20 remaining natural teeth with dentures | 1.94 (1.09–3.44) | 1.48 (0.81–2.71) | 17.4 | 10.0 |
| <20 remaining natural teeth without dentures | 2.36 (1.11–5.05) | 2.06 (0.95–4.46) | 20.5 | |
| <20 remaining natural teeth with dentures | 1.25 (0.74–2.13) | 0.85 (0.48–1.52) | 12.0 | |
| Plaque score (ref. <1) | ||||
| ≥1 | 1.83 (1.28–2.61) | 1.53 (1.04–2.24) | 15.6 | 15.6 |
| Periodontal status (ref. non-periodontitis) | ||||
| Periodontitis | 1.45 (1.03–2.03) | 1.16 (0.81–1.66) | 12.8 | 15.3 |
OR: odds ratio; CI: confidence interval; PAF: population attributable fraction; NA: not applicable; BMI: body mass index.
aThe multivariable logistic regression model included sex and all other risk factors with a significance level of P < 0.05 in the univariate analysis (model 1).
bAge in years scaled to decades.
Predictors of rate of reduction in salivary flow during the follow-up period determined by using stepwise multivariable linear regression.
|
| SE | Standardized |
|
| |
|---|---|---|---|---|---|
| Salivary flow rate (mL/min) | 0.116 | 0.009 | 0.348 | 12.952 | <0.001 |
| Age per decadea | 0.058 | 0.011 | 0.132 | 5.100 | <0.001 |
| Sex (men = 0; women = 1) | 0.116 | 0.024 | 0.132 | 4.853 | <0.001 |
| Plaque score (<1 = 0; ≥1 = 1) | 0.065 | 0.026 | 0.066 | 2.526 | 0.012 |
The analysis also included use of antihypertensive agents, which was excluded in the final model.
Parameters of model: F = 46.858; adjusted R 2 = 0.118; P < 0.001.
aAge in years scaled to decades.